BRPI0820875A2 - Moléculas de ligação ao receptor de 0x40 - Google Patents

Moléculas de ligação ao receptor de 0x40

Info

Publication number
BRPI0820875A2
BRPI0820875A2 BRPI0820875-1A BRPI0820875A BRPI0820875A2 BR PI0820875 A2 BRPI0820875 A2 BR PI0820875A2 BR PI0820875 A BRPI0820875 A BR PI0820875A BR PI0820875 A2 BRPI0820875 A2 BR PI0820875A2
Authority
BR
Brazil
Prior art keywords
receptor binding
binding molecules
molecules
receptor
binding
Prior art date
Application number
BRPI0820875-1A
Other languages
English (en)
Inventor
Jing Min
Yanli Wu
Rory Francis Finn
Barrett Richard Thiele
Wei Liao
Ronald Paul Glaude
Arvind Rajpal
Timothy Joseph Paradis
Peter Brams
Brigitte Devaux
Yi Wu
Kristopher Toy
Heidi N Leblanc
Haichun Huang
Original Assignee
Bristol Myers Co
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40552119&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0820875(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bristol Myers Co, Pfizer filed Critical Bristol Myers Co
Publication of BRPI0820875A2 publication Critical patent/BRPI0820875A2/pt
Publication of BRPI0820875B1 publication Critical patent/BRPI0820875B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2878—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
BRPI0820875-1A 2007-12-14 2008-12-11 Molécula de ligação isolada, anticorpo monoclonal humano, composição, molécula de ácido nucleico, vetor e célula hospedeira BRPI0820875B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1394707P 2007-12-14 2007-12-14
US61/013.947 2007-12-14
PCT/US2008/086417 WO2009079335A1 (en) 2007-12-14 2008-12-11 Binding molecules to the human ox40 receptor

Publications (2)

Publication Number Publication Date
BRPI0820875A2 true BRPI0820875A2 (pt) 2015-06-16
BRPI0820875B1 BRPI0820875B1 (pt) 2021-10-19

Family

ID=

Also Published As

Publication number Publication date
CA2949772A1 (en) 2009-06-25
US20090214560A1 (en) 2009-08-27
DK2242771T3 (da) 2013-08-26
DK2594590T3 (en) 2015-01-12
US9840562B2 (en) 2017-12-12
AR109355A2 (es) 2018-11-21
IL245876A0 (en) 2016-07-31
PH12015500806B1 (en) 2015-12-02
IL245876A (en) 2017-08-31
SI2242771T1 (sl) 2013-09-30
JP2015110558A (ja) 2015-06-18
EP2594590A1 (en) 2013-05-22
IL206297A (en) 2016-06-30
CN101918447A (zh) 2010-12-15
IL239674A (en) 2017-08-31
EP2594590B1 (en) 2014-11-12
JP6248024B2 (ja) 2017-12-13
AR069681A1 (es) 2010-02-10
SG186656A1 (en) 2013-01-30
ES2425269T3 (es) 2013-10-14
KR20150061041A (ko) 2015-06-03
EP2851374B1 (en) 2017-05-03
HUE032735T2 (en) 2017-10-30
AU2008338591A8 (en) 2014-02-20
CL2008003706A1 (es) 2009-06-12
PL2242771T3 (pl) 2013-12-31
PT2594590E (pt) 2015-01-14
JP6420379B2 (ja) 2018-11-07
PH12015500806A1 (en) 2015-12-02
US8236930B2 (en) 2012-08-07
RU2010129045A (ru) 2012-01-20
ES2526887T3 (es) 2015-01-16
EP3239178A1 (en) 2017-11-01
HRP20141188T8 (en) 2015-05-22
US20150218279A1 (en) 2015-08-06
AU2008338591B8 (en) 2014-02-20
CN101918447B (zh) 2014-06-11
US20110206681A1 (en) 2011-08-25
US7960515B2 (en) 2011-06-14
IL239674A0 (en) 2015-08-31
DK2851374T3 (en) 2017-06-19
US20220002428A1 (en) 2022-01-06
EP2851374A1 (en) 2015-03-25
PT2242771E (pt) 2013-08-29
SG10201604770VA (en) 2016-08-30
IL206297A0 (en) 2010-12-30
CA2707773A1 (en) 2009-06-25
MX2010006466A (es) 2010-09-28
ZA201003579B (en) 2011-07-27
TW200932268A (en) 2009-08-01
EP2242771A1 (en) 2010-10-27
KR20100102657A (ko) 2010-09-24
CO6280541A2 (es) 2011-05-20
JP2017114866A (ja) 2017-06-29
JP2019030313A (ja) 2019-02-28
WO2009079335A1 (en) 2009-06-25
AU2008338591B2 (en) 2014-01-23
US20180057600A1 (en) 2018-03-01
HRP20141188T1 (en) 2015-03-13
US10196452B2 (en) 2019-02-05
US9028824B2 (en) 2015-05-12
ES2628093T3 (es) 2017-08-01
PT2851374T (pt) 2017-06-20
CA2707773C (en) 2017-01-10
SI2594590T1 (sl) 2015-03-31
EP2242771B1 (en) 2013-07-17
SI2851374T1 (sl) 2017-08-31
PA8807601A1 (es) 2009-09-17
PE20091269A1 (es) 2009-09-09
JP5761997B2 (ja) 2015-08-12
JP2011505836A (ja) 2011-03-03
UY31533A1 (es) 2009-08-03
US20120225086A1 (en) 2012-09-06
KR101577843B1 (ko) 2015-12-16
US20190135932A1 (en) 2019-05-09
PL2594590T3 (pl) 2015-05-29
AU2008338591A1 (en) 2009-06-25

Similar Documents

Publication Publication Date Title
DK3222615T3 (da) Psma-bindende stoffer og anvendelser deraf
IL245876A0 (en) Human ox40 receptor binding molecules
ZA200806492B (en) Binding molecules
IL234081B (en) Antibody binds cd3–epsilon in different species
BRPI0819718A2 (pt) Mistura de documentos
IL201340A (en) Antidote 3dc - epsilon in various species
GB2449354B (en) Binding protein
DK2077977T3 (da) Vedvarende bindemiddel til ikke-vævet materiale
ZA200901815B (en) Binding molecules
EP2004735A4 (en) ACTIVATED POLYMERS BINDING BIOLOGICAL MOLECULES
EP2156186A4 (en) BINDING REAGENTS WITH SMALL EPITOP BINDING MOLECULES
ZA200905210B (en) Binding members for ige molecules
EP2202088A4 (en) BINDING DEVICE
GB0716542D0 (en) Endotoxin biosensor
HK1129349A1 (en) Folder binding device
EP2271981A4 (en) INFORMATION PROCESSING DEVICE FOR DATA AND CONTROL FILES
BRPI0915343A2 (pt) polipeptídeos funcionalizados
ZA201008335B (en) Interleukin-21 receptor binding proteins
AT506422A3 (de) Snowboardbindung
BRPI0817098A2 (pt) Meios visuais para o aumento de qualidade de confeitos
ES1068038Y (es) Dispositivo de encuadernacion practicable
GB0718073D0 (en) Analysing the binding of cell membrane bound molecules
AT505068A3 (de) Skibindung
GB0711244D0 (en) Binding molecules
ES1064765Y (es) Dispositivo de encuadernacion para hojas perforadas

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06G Technical and formal requirements: other requirements [chapter 6.7 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 11/12/2008, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO.

B25G Requested change of headquarter approved

Owner name: BRISTOL-MYERS SQUIBB COMPANY (US) ; PFIZER, INC. (US)